LKT Labs

Biochemicals for Life Science Research

Belinostat

Belinostat

Product ID B1746
Cas No. 414864-00-9
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $92.90 In stock
10 mg $142.60 In stock
Bulk Quote

Quicklinks

Description

Belinostat is a histone deacetylase (HDAC) inhibitor that exhibits antiviral and anticancer chemotherapeutic activities. Belinostat is approved for use in humans in the treatment of T cell lymphoma and is currently in clinical trials as a potential treatment for other leukemias and lymphomas. In pancreatic cancer cells, belinostat induces apoptosis in an AMPK-dependent manner. In other cellular models, this compound decreases HIV release from macrophages by degrading intracellular HIV.

Product Info

Cas No.

414864-00-9
Purity

≥98%
Formula

C15H14N2O4S
Formula Wt.

318.35
Synonym

PXD101
Solubility

DMSO 64 mg/mL (201.03 mM) Water Insoluble Ethanol Insoluble
Appearance

Pale yellow powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

B1746 MSDS PDF
Info Sheet

B1746 Info Sheet PDF

References

Campbell GR, Bruckman RS, Chu YL, et al. Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1. J Biol Chem. 2015 Feb 20;290(8):5028-40. PMID: 25540204.

Foss F, Advani R, Duvic M, et al. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma. Br J Haematol. 2014 Nov 17. [Epub ahead of print].
PMID: 25404094.

Kirschbaum MH, Foon KA, Frankel P, et al. A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study. Leuk Lymphoma. 2014 Oct;55(10):2301-4. PMID: 24369094.

Wang B, Wang XB, Chen LY, et al. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis. Biochem Biophys Res Commun. 2013 Jul 19;437(1):1-6. PMID: 23743198.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A0534

    Abiraterone

    Progesterone derivative; Cyp17A1 inhibitor.
    ≥99%
  • I4659

    Iloperidone

    Benzisoxazole phenylethanone; D2 and 5-HT2A antago...
    ≥99%
  • R5700

    Ro 61-8048

    Kynurenine 3-hydroxylase inhibitor.
    ≥99%
  • T0100

    10-Deacetyltaxol

    Taxane found in Taxus; microtubule depolymerizatio...
    ≥98%
  • N1744

    Nelarabine

    Nucleoside (guanosine) analog; DNA chain terminato...
    ≥98%
  • T1750

    Temocapril Hydrochloride

    ACE inhibitor.
    ≥98%
  • V1745

    Veliparib

    PARP inhibitor.
    ≥99%
  • I5753

    Ionomycin Calcium

    Polyether Ca2+ ionophore.
    ≥98%
  • P0260

    Papain Inhibitor

    Peptide produced in tomato leaves; potential cathe...
    ≥95%
  • J0001

    J-147

    Phenyl hydrazide; neuronal oxidative stress inhibi...
    ≥98%
  • G3354

    Ginkgolide A

    Terpene lactone found in Ginkgo; GSK-3β inhibitor...
    ≥95%
  • L1884

    Levosimendan

    Ca2+ sensitizer; ATP-sensitive K+ channel activato...
    ≥98%
  • P698583

    Prostaglandin E2

    Prostaglandin E2 is the principal metabolic produc...
    ≥99%
  • P0218

    Paeoniflorin

    Found in Paeonia; L-type Ca2+ channel blocker.
    ≥98%
  • V0352

    Vandetanib

    RET, EGFR, VEGFR2 inhibitor.
    ≥98%
  • P2000

    PF-03758309 Dihydrochloride

    PAK4 inhibitor.
    ≥99%, ≥99%ee
  • P6903

    Prasugrel

    Thienopyridine; P2Y12 antagonist.
    ≥98%
  • S6247

    Splitomicin

    SIRT1/2 inhibitor.
    ≥98%
  • T3310

    Ticlopidine Hydrochloride

    Thienopyridine; P2Y12 antagonist.
    ≥98%
  • A0967

    Adrenocorticotropic Hormone (1-17), human

    Endogenous peptide hormone fragment, involved in s...
    ≥95%